25 Nov 2013 --- Nutranomics, Inc. is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC to acquire the worldwide exclusive marketing and distributing rights to GenEpic, a natural therapeutic treatment formula currently the subject of an IRB reviewed (FDA regulated) phase II human clinical study on prostate cancer treatment and recovery.
